(19)
(11) EP 0 944 651 A2

(12)

(43) Date of publication:
29.09.1999 Bulletin 1999/39

(21) Application number: 97920293.0

(22) Date of filing: 09.04.1997
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 31/ 48( . )
A61P 35/ 00( . )
C07K 14/ 475( . )
C07K 16/ 32( . )
C12N 15/ 12( . )
C12Q 1/ 68( . )
A61K 48/ 00( . )
A61K 31/ 00( . )
A61K 38/ 00( . )
C07K 14/ 47( . )
C07K 14/ 82( . )
C12N 5/ 10( . )
C12P 21/ 08( . )
G01N 33/ 50( . )
(86) International application number:
PCT/US1997/005930
(87) International publication number:
WO 1997/038085 (16.10.1997 Gazette 1997/44)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 10.04.1996 US 19960015167P
05.06.1996 WO 1996US09286
06.06.1996 US 19960019202P
11.07.1996 US 19960678280

(71) Applicant: California Pacific Medical Center
San Francisco, CA 94115 (US)

(72) Inventors:
  • SMITH, Helene
    San Francisco, CA 94110 (US)
  • CHEN, Ling-Chun
    Fremont, CA 94536 (US)

(74) Representative: Goldin, Douglas Michael 
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) GENES AMPLIFIED IN CANCER CELLS